L. Young

Central vs site outcome adjudication in the IRIS trial.

K. Furie, C. Viscoli, W. Kernan, 2022, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance

K. Furie, C. Viscoli, W. Kernan, 2022, Diabetes, obesity & metabolism.

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized controlled trials

Deepak L. Bhatt, M. Suchard, H. Krumholz, 2023, medRxiv.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

D. Tanné, K. Furie, C. Viscoli, 2016, The New England journal of medicine.

Consensus Reports

R. P. Robertson, B. Howard, R. Bonow, 2011, Diabetes Care.

Abstract 13661: An Adaptive Strategy of Predictive Enrichment to Increase Efficiency of Randomized Clinical Trials Using Machine Learning: A Simulation of the IRIS Trial

M. Suchard, W. Kernan, S. Inzucchi, 2022, Circulation.

Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs)

K. Furie, C. Viscoli, W. Kernan, 2009, Neurology.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

C. Viscoli, W. Kernan, M. Bursztyn, 2016, The New England journal of medicine.

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

K. Furie, C. Viscoli, W. Kernan, 2017, Circulation.